Answers are grounded in this paper and cite their sources.
▪"The Secret of Happiness is Knowledge, and the Secret of Knowledge is an Inquiring Mind; Not to Idly Stand Aside from the Eternal Quest to Heal.” (Adapted from Thucydides, ca. 460–400 BC). Few human illnesses today are more challenging medically, scientifically, and socio-economically than the world-wide “nonspecific” inflammatory bowel diseases (IBDs): ulcerative colitis and Crohn's disease. They did occur several centuries ago, but they are essentially diseases of the 20th century. They affect men and women, children and young adults, and all ethnic groups, and involve virtually all bodily systems in addition to the gastrointestinal tract. Ulcerative colitis and Crohn's disease have emerged as major biomedical problems. Prevailing etiologic concepts, often originating in 20th century clinical observation, today provide exciting opportunities for meaningful research. More physicians and scientists now are involved in the study of IBDs and, like Ariadne of Greek mythology, are endeavoring to negotiate the complex biomedical maze of IBDs. As the story goes, Ariadne, daughter of Pasiphae and King Minos of Crete, fell in love with the Athenian hero Theseus, and with a “thread of glittering jewels” helped him escape the imprisoning Labyrinth after he had slain the evil Minotaur (half bull, half human). Metaphorically, our hope for the 21st century is conquest of the “IBD Minotaur.” This report retraces my initial interest in IBDs and my earliest observations; more details are provided in Kirsner's Origins and Directions of Inflammatory Bowel Disease (published by the Kluwer Academic Press, 2002), including a clarification of the pivotal early Mt. Sinai (New York) experience1 with Crohn's disease. In particular, it recognizes the contributions of Eli Moschowitz and A. O. Wilensky, Surgeons L. Ginzburg and G. Oppenheimer, all of the Mt. Sinai Hospital, and B. B. Crohn and Surgeon A. A. Berg to the 1932 presentation in New Orleans. My interest in IBDs began in January 1936 when I undertook the care of a 40-year-old emaciated woman, who was brought to the University of Chicago Medical Center in desperate condition with severe “ulcerative colitis,” a virtually unknown illness at the time. I had not seen a similar clinical situation during my medical school days (1929-1933) in Boston. Lacking antibacterial drugs, steroids, immunosuppressants, and adequate support measures, she rapidly succumbed to the disease. Having witnessed her daily decline, yet unable to help, the death of this patient challenged me to learn more about IBDs. The 1909 London symposium reviewing 317 patients with ulcerative colitis, collected from 5 local hospitals,2 including instances dating back to the 19th century, indicated that ulcerative colitis was not a new disease. Similarly, a 1901 paper, “A Study of Chronic Hyperplastic Tuberculosis of the Intestine with Report of a Case,” by A. J. Lartigau of Columbia University, reviewing a substantial German and French literature prior to the key 1913 (Dalziel) and the 1932 Mt. Sinai Crohn's disease reports, revealed the early existence of Crohn's disease, initially misdiagnosed as intestinal tuberculosis. My interest in the historical aspects of ulcerative colitis and Crohn's disease has produced several comprehensive reviews.3,–5 Initially, assisted by gastrointestinal fellows, I focused on the clinical nature of ulcerative colitis, its mode of onset, clinical manifestations, nutritional aspects, the complications, including the increased risk of colorectal cancer; and the differentiation of ulcerative colitis and Crohn's colitis. In 1948, with W. L. Palmer and G. Maimon, I described the course of 120 patients with ulcerative colitis6 and in 1951, the course of 40 patients with regional enteritis.7 With M. Sparberg and J. J. Fennessy, a 1966 study reviewed 220 patients with ulcerative proctitis and mild ulcerative colitis.8 An expanded computerized study in 1971, with B.G.H. Rogers and Linda Clark, reviewed the demography and course of 1400 patients with IBD seen at the University of Chicago. All series included children, teenagers, and young adults; some had repeatedly received antibacterial medication for respiratory infections. Several isolated clinical experiences were of interest, but unrevealing. For example, sleep therapy had been recommended for ulcerative colitis by European observers. By chance, one patient in 1937 was receiving larger amounts of sedation than prescribed. She slept almost continuously for 7 days. While asleep, the number of bowel movements diminished, but the colitis persisted. An intriguing clinical experience was the abrupt cessation of diarrhea in a woman with ulcerative colitis who became temporarily psychotic; the diarrhea returned when the psychosis receded. I became aware of the varied clinical and laboratory manifestations and the numerous local and systemic complications, including the nutritional depletion associated with the growth retardation of children with IBD, later studied in detail by colleagues, Drs. Barbara Kirschner and Irwin Rosenberg. I soon learned that the undernourished patient (with iron-deficiency anemia and lowered serum albumin) did not respond fully to otherwise effective medication. Clinical studies revealed a wide variety of IBD-related problems (retardation of growth in children, ocular complications, pyoderma gangrenosum, liver disease, osteoporosis, arthritis). A definitive study of toxic megacolon complicating ulcerative colitis, with Charles Norland, in 1969, provided important clinical information on the early diagnosis and risk factors (undernutrition, electrolyte depletion, morphine for abdominal pain).9 Two studies with AP Klotz and M. van Woert (1951 and 1964) documented the previously unrecognized radiologic reversibility of severe ulcerative colitis, after prolonged clinical quiescence of the disease.10,11 Bleeding from the colon and rectum, a characteristic symptom, often was profuse, requiring blood transfusions, which reflected the hypervascularity of the inflamed bowel, attributed by early observers to the mast cell release of histamine, increasing capillary congestion. Clinical observations suggested various etiologic possibilities; including bacteria (postinfection IBD, overuse of oral antibiotics for respiratory illness in children, and fulminating ulcerative colitis after aureomycin for acne), familial occurrences, especially in Crohn's disease (genetic), and the individually variable course of IBD (immunology, genetics). The association of Crohn's disease with several genetic syndromes suggested a genetic relationship.12 Patients with ulcerative colitis manifested allergic disorders (e.g., hay fever, allergic rhinitis), suggesting an immunologic background. Additional clinical studies disclosed families with combinations of ulcerative colitis and Crohn's disease in married couples and a higher incidence of complications in familial IBD.13,–15 The NOD2 Card 15 gene identified simultaneously by P. Hugot (Paris) and Judy Cho (University of Chicago) stimulated much research on the complex genetics of IBD. The rapid advances in this aspect of IBD have been described recently by Russell et al16 and Vermeire et al.17 The etiologic hypotheses of the 1930s: Allergy to foods (milk, eggs, wheat), tree and grass pollens, “gastrointestinal reactions” to corn flakes or margarine, nutritional (vitamin deficiencies, “intestinal protective factor"), antecedent bacterial infection (dysentery bacillus, lymphopathia venereum, amebic dysentery, mycobacteria), and psychogenic disorders emphasizing “maternal dominance,” and an “ulcerative colitis personality” in “immature, passive, overly dependent individuals"; had little convincing supporting evidence.18 The psychiatric emphasis was supported by papers such as “Emotion and Diarrhea,”19 and “The Psychogenic Origin of Organic Diseases.”20 I soon was made aware of “real life” dependency, when a male patient showed me a map he had made locating public toilets on the route from his home in Highland Park to the University of Chicago.21 Esther M. Sternberg has described the biochemical and molecular basis of emotionally induced stress.22 I initially was interested in the of bacteria as the of ulcerative colitis and especially Crohn's disease, and I was by the of IBD in the of of the intestinal inflammatory diseases with including from of a regional in did not this in this increased after I had patients with gastrointestinal from at The University of Chicago and Crohn's disease in young had studied for in the of this important to the by P. of in This the increased and of to a incidence of diseases and to in the of with the of and IBD A the lowered incidence of disease, has been children on The protective involved early to bacterial of in and I was aware of the intestinal its by as the of disease and by intestinal and by of a as a I to this major key to the IBD later studied by and Charles are in the of IBD, as reviewed by gastrointestinal a for the bacterial in the of IBDs. in the and after of the and I for and with focused on and the with This experience have me that the bacterial in IBD (e.g., the intestinal than in but I was not to With the with the Chicago of amebic dysentery, I a young woman after from the amebic had severe ulcerative colitis. She later of of the infection of the colon had been a risk for ulcerative colitis. young patients the of ulcerative colitis to the oral of antibacterial medication (e.g., oral for and A young aureomycin for a fulminating ulcerative colitis, a and I an in the intestinal the an inflammatory A similar of in a previously who a severe ulcerative colitis after an in to involve a intestinal In an early with the of from patients with ulcerative colitis in by in the In with of ulcerative colitis the of to became at the made by the P. Hugot of has suggested the of and as of in an foods are produced and at the is yet the my IBD studies were by the of and psychogenic concepts, during my medical in the European and of at I with ulcerative colitis. In condition had and they had this information to days after the of in I patients with IBD at a French from at major local after had This was my with IBD I returned to the from in the of I with on the of and factors in the of IBD In I and (University of undertook the of in patients with IBD, in the of the This comprehensive study of new biochemical of in and The of in the bowel in patients with ulcerative colitis and Crohn's disease, had not been fully With the of I the of the colon and to and rapid of the in and colitis In the of amounts of to the colon or in retardation in children, the of of the colon and rectum, and liver disease in ulcerative colitis and the intestinal abdominal and in Crohn's disease were challenging clinical problems. The of in ulcerative colitis and its in Crohn's disease were a when in by of documented by M. of and J. of and in our and the In 1948, I the of a my with Crohn's the I was by disease and as to the increased of to a of the associated with increased for the of intestinal bacteria (e.g., or the induced of an in the bowel et in for the and the of in Crohn's disease in colon This and familial occurrences, including families with to 5 with ulcerative colitis and Crohn's disease, and Crohn's disease in and studies of the familial of IBD with and later In after patients ulcerative colitis after from which had I was of an to IBD, by or A study of ulcerative colitis, with A. Klotz and M. had revealed of of the of the of the colon and in ulcerative colitis, an early of the in to intestinal immunologic the of and the of the et recently documented increased intestinal intestinal described as in an experience in the Allergy (University of I an interest in the of allergic in IBD. from (e.g., and a of ulcerative colitis as an disease in the with of the bowel and as This was supported by of the of the intestinal and I produced in and I colon in ulcerative colitis like O. and P. of not and this aware of immunologic to foods in the gastrointestinal and young children with the of the bowel to in the had not been M. and I documented the of the colon to and In as the B. and produced the complex in the This was in and and (University of Chicago) the of in the colitis In G. and of produced for the of local and in the of ulcerative The of and as the of the the intestinal from an intestinal and the that IBD is by a to of the intestinal as later by Charles had not yet A had documented the and the of of the gastrointestinal that had A with M. reviewed and definitive manifestations of in the gastrointestinal and a with and papers provided and for immunologic studies of IBD. A with G. the increasing immunologic of The of the of the bowel increased immunologic including P. of the protective of and J. soon identified the The of oral had been documented in by at the University of Chicago in it was by and L. New In addition to and identified included the cell cell L. and cell and to the intestinal in the inflammatory I was aware of the biochemical studies of of in the and molecular studies of but I was to this important to and ulcerative colitis the of as the in bowel in were observations on Crohn's disease from the University of 1936 by and of an of the bowel as the of Crohn's disease, my interest, especially after an had been identified in the bowel from one of my from a of the Crohn's the of or with and emerged from this the and of the Crohn's disease bowel to the intestinal in the Crohn's disease have and have to the increased of the of Crohn's disease and ulcerative colitis, as described by O. B. G. and and by G. and W. were in the and including of of liver or (e.g., of an of and of the and of hypotheses had been in of the to an was in but in the did with IBD in the with the nutritional deficiencies, the of nutritional by the increased oral of by was to the support of the had the of who and in the of the IBD were by who helped patients and families with this patients received I a documented to in patients with severe ulcerative colitis. Two clinical experiences are An colitis in a young woman who had been after receiving the patient was to patient with severe ulcerative colitis in the Two later she a and In she her and a In a I had to bowel and prolonged by of daily of as a of in with In the were to and were to of or of I research. from the intestinal in ulcerative colitis, and (University of Chicago) repeatedly the blood were as a support was the of the medical of ulcerative colitis in the early 20th but with and and support The exciting of in in increased of more effective of the disease and a new in the of IBD. in studies of the of the and antibiotics on the the initial in bacterial were and associated with the of was to fully or the and of the was in the of some patients with ulcerative colitis and the bacterial and it became a of especially for the complications of Crohn's disease and ulcerative colitis The of in by and an the and which was for the of effective in the of patients with ulcerative colitis. later was to the of and the of this became the of I to as therapy for ulcerative colitis. became to patients with ulcerative colitis and with Crohn's disease in The of new IBD patients to the University of Chicago increased By the as as new patients were seen and the of IBD patients More antibiotics had initial and clinical in IBD were by The of and in was a in the of human including IBD. In 1951, W. L. Palmer and in showed the of and in this was documented by the Two patients with ulcerative colitis of the at after the of 40 in one patient and in the The and bowel and the The and the of the early days patients and physicians at the of with this medication an of and In our one male patient with ulcerative colitis including of and young with ulcerative colitis a with clinical The was as the of and The early problems and the complications of therapy as learned to in IBD. in the early of the inflammatory are not recommended for A 1966 study our early experience with in ulcerative colitis, of the medication of severe toxic the liver and the with J. A. J. B. and J. in the of in the of ulcerative colitis and especially in Crohn's the of B. and of New was as an effective medication for IBD, including its in the and of M. B. and G. recently have a comprehensive of In the the of ulcerative colitis was in its early was a of the colon on the of the was in the hope of later bowel the colon from its at the to the rectum, the bowel with the in an to bowel became when was for ulcerative colitis, of the colon and and the of an was the effective and of the were to A major in 1951, in London and of the almost simultaneously the the A major early for patients and physicians when the was in and a soon in New in the in support of patients requiring an and information its The support at the was at the University of by and this expanded the The Chicago was as the In the the and with the the of the to ulcerative colitis and, for the of provided a more for disease. In Crohn's disease of the of the bowel with was of bowel and of the this often was by disease, the became as much bowel as to bowel In the of the and to the regional of the bowel and regional of the colon became at the University of Chicago. By the Crohn's disease had more than ulcerative colitis in our patient now were at new patients and were The increasing of patients with ulcerative colitis and especially with Crohn's disease, the of medical and the not for increased the of with physicians and with patients and families as to the nature of IBD and its A of IBD patients was by Linda and B. G. In the B. a more comprehensive IBD I numerous with patients and as to the research in IBD at the time. The of the of a had ulcerative colitis, and the support of the of were especially in the and L. in the early helped the to IBD research at the University of Chicago. the and M. in addition to research became a key in several to IBD, including with me on the of the for and of the of in the of a of and Chicago patients and the of and has provided and now for has been a major to our IBD research for contributions were important to the IBD research of on the of the intestinal and in the support of Judy of the gene in to Crohn's disease The laboratory at the University of Chicago to provide for genetic the increasing of IBD, to research interest in IBD. I in the early to this to the of the Study by me in the to research in IBD, with initially had been by study of the medical and L. of the of and at the University of and with the of to the of the Study of the in to in addition to for this study I J. W. (University of and now reviewed by and the of the Study I a symposium in in January a of interested in IBD, scientists all and by The of this to a at the University of Chicago provided new opportunities for the of and stimulated research on IBD. The Study provided support in the of and in the of to support research in during the of the and with the of of ulcerative colitis and with the of research in the M. supported the of the for in Ulcerative The Medical to this included such as J. A. W. (University of J. M. (University of O. (University of L. G. (University of later at and J. B. and W. L. Palmer (University of M. the of on ulcerative colitis and Crohn's disease from the were to of and were an important of information on IBD. Additional included P. A. and P. The to with patients and families on support for research as to the nature of ulcerative colitis and Crohn's disease increased this M. the of a “The by the the of The to this was by the University of had of severe ulcerative colitis. “The was the on ulcerative colitis to for public and its to increasing of the IBD interest in IBD increased after the illness of the from a later an abdominal of an intestinal from an unrecognized regional An intestinal was the bowel a had intestinal and he succumbed later to The at that became aware of the research in Crohn's disease and made a of for this I received from this a addition to my research More this the of interest in supporting IBD research. As was public or in support of IBD the of the for and in New the of and Irwin M. and and in in the New this with numerous the I as of the during the increased and the for and now the Crohn's and of is the for information on IBD to patients and to research on IBD, and young in IBD, new research and effective with the the the of and By the new clinical and of the IBDs had been to a comprehensive The of Inflammatory Bowel with of the in and was an New have 5 The Kirsner's Inflammatory Bowel by the (University of and J. by in The and of the information on IBD and has been by the The IBD situation today is from the IBD is a of the medical and is a major interest of physicians and medical the and IBD now is as one of the important medical problems of our time. In medical and medical IBD has the disease for biomedical the gastrointestinal tract. As a of the of the now are more IBD of has made important contributions to the of of IBD for the and on IBDs. Clinical including Drs. B. (University of Chicago) and have made clinical and contributions to the of especially Crohn's in the and the of and in IBD. a with IBD, a are to therapy for The is century research has indicated the protective nature of oral gastrointestinal to learn more of this and it to oral is the of Crohn's disease intestinal to the disease after and an intriguing the the the intestinal the and growth and the of In the study of now have been including the important in numerous the of an important in and more is yet to learned of and of the of genetic of IBD, by the and of the human the of genetic therapy for IBD. is a of factors in the of a variety of of various of cell and involved in intestinal have not yet identified the or of IBD, have learned much about the nature of diseases and of the patients and The study of IBD has to important advances in one of the more important is the of the gastrointestinal in our have aware of the of genetic and gastrointestinal the gastrointestinal and aspects of IBD including the of and the of new of the the intestinal the bacteria and and and and In such a complex and the of scientists including and with patients and and the are I have been with the the interest, the and the of patients and I have been to as I have been to with the gastrointestinal and with physicians the of in the and care of the IBD With such the for IBD now than I the of the French and by to involved in the and the of the and of the ethnic and the and of our and the increasing of our the of the of the of and the of this hope in a in a or in a and yet in a I that hope is and by men and like and the of our and the of this hope and this the to IBD.
No takes yet. Share an insight, caveat, or question.
Joseph B. Kirsner (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: